$122 Million is the total value of CAXTON CORP's 52 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 12.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | XERIS BIOPHARMA HOLDINGS INC | $18,490,000 | – | 6,310,546 | +100.0% | 15.11% | – | |
| CRDF | CARDIFF ONCOLOGY INC | $15,158,000 | -9.8% | 2,522,083 | 0.0% | 12.39% | -9.0% | |
| SCYX | Buy | SCYNEXIS INC | $10,668,000 | +28.7% | 1,748,786 | +11.8% | 8.72% | +29.8% |
| SVRA | Buy | SAVARA INC | $8,577,000 | -9.9% | 6,916,551 | +0.3% | 7.01% | -9.1% |
| MTEM | MOLECULAR TEMPLATES INC | $8,381,000 | -41.6% | 2,137,991 | 0.0% | 6.85% | -41.1% | |
| GLD | SPDR GOLD TR | $6,979,000 | +4.1% | 40,820 | 0.0% | 5.70% | +5.0% | |
| SRRA | Sell | SIERRA ONCOLOGY INC | $5,717,000 | -41.1% | 262,969 | -40.6% | 4.67% | -40.6% |
| RZLT | Buy | REZOLUTE INC | $5,705,000 | +79.8% | 1,193,473 | +181.3% | 4.66% | +81.4% |
| CTIC | Buy | CTI BIOPHARMA CORP | $5,553,000 | +88.2% | 2,239,300 | +123.9% | 4.54% | +89.8% |
| PSTH | New | PERSHING SQUARE TONTINE HLDG | $4,476,000 | – | 227,000 | +100.0% | 3.66% | – |
| SPY | Buy | SPDR S&P 500 ETF TRtr unit | $3,315,000 | +122.0% | 6,980 | +100.6% | 2.71% | +124.0% |
| LUXA | LUX HEALTH TECH ACQUISITION | $1,960,000 | -0.1% | 200,000 | 0.0% | 1.60% | +0.8% | |
| ADXN | ADDEX THERAPEUTICS LTDsponsored ads | $1,673,000 | -30.2% | 265,940 | 0.0% | 1.37% | -29.6% | |
| EFA | ISHARES TRmsci eafe etf | $1,495,000 | +0.9% | 19,000 | 0.0% | 1.22% | +1.7% | |
| AACU | ARES ACQUISITION CORPORATIONunit 99/99/9999 | $1,387,000 | +0.3% | 139,680 | 0.0% | 1.13% | +1.2% | |
| INTU | Buy | INTUIT | $1,279,000 | +25.9% | 1,989 | +5.6% | 1.05% | +27.1% |
| GOOG | Buy | ALPHABET INCcap stk cl c | $1,155,000 | +16.4% | 399 | +7.3% | 0.94% | +17.4% |
| MSFT | Buy | MICROSOFT CORP | $1,109,000 | +28.7% | 3,299 | +7.9% | 0.91% | +29.8% |
| SPGI | Buy | S&P GLOBAL INC | $1,062,000 | +20.7% | 2,251 | +8.6% | 0.87% | +21.7% |
| MCO | Buy | MOODYS CORP | $1,015,000 | +20.1% | 2,600 | +9.2% | 0.83% | +21.2% |
| FB | Buy | META PLATFORMS INCcl a | $955,000 | +9.8% | 2,840 | +10.7% | 0.78% | +10.8% |
| AMT | Buy | AMERICAN TOWER CORP NEW | $948,000 | +23.4% | 3,240 | +12.0% | 0.78% | +24.6% |
| WHR | Buy | WHIRLPOOL CORP | $917,000 | +29.0% | 3,906 | +12.0% | 0.75% | +30.2% |
| NFLX | Buy | NETFLIX INC | $912,000 | +10.1% | 1,513 | +11.5% | 0.75% | +11.2% |
| MDLZ | Buy | MONDELEZ INTL INCcl a | $901,000 | +28.7% | 13,582 | +12.8% | 0.74% | +30.0% |
| TDG | Buy | TRANSDIGM GROUP INC | $895,000 | +15.8% | 1,407 | +13.7% | 0.73% | +16.9% |
| MA | Buy | MASTERCARD INCORPORATEDcl a | $887,000 | +16.9% | 2,469 | +13.0% | 0.72% | +17.9% |
| V | Buy | VISA INC | $863,000 | +10.2% | 3,981 | +13.3% | 0.70% | +11.0% |
| CRM | Buy | SALESFORCE COM INC | $850,000 | +4.9% | 3,346 | +12.1% | 0.70% | +5.9% |
| CHTR | Buy | CHARTER COMMUNICATIONS INC Ncl a | $802,000 | +3.9% | 1,230 | +15.9% | 0.66% | +4.8% |
| DIS | Buy | DISNEY WALT CO | $787,000 | +5.8% | 5,082 | +15.6% | 0.64% | +6.6% |
| CVNA | Buy | CARVANA COcl a | $769,000 | -11.6% | 3,316 | +14.9% | 0.63% | -10.8% |
| FICO | Buy | FAIR ISAAC CORP | $754,000 | +27.6% | 1,739 | +17.1% | 0.62% | +28.6% |
| PYPL | Buy | PAYPAL HLDGS INC | $685,000 | -13.9% | 3,633 | +18.8% | 0.56% | -13.2% |
| FLAC | FRAZIER LIFESCIENCES ACQU CO | $624,000 | -0.8% | 64,000 | 0.0% | 0.51% | 0.0% | |
| BTWN | BRIDGETOWN HOLDINGS LTD | $616,000 | +0.2% | 62,688 | 0.0% | 0.50% | +1.2% | |
| SSAAU | SCIENCE STRATEGIC ACQ ALPHAunit 01/20/2026 | $613,000 | -0.8% | 62,000 | 0.0% | 0.50% | 0.0% | |
| EIGR | Sell | EIGER BIOPHARMACEUTICALS INC | $607,000 | -35.4% | 116,884 | -16.9% | 0.50% | -34.8% |
| HMCOU | HUMANCO ACQUISITION CORPunit 12/08/2023 | $585,000 | -1.2% | 57,724 | 0.0% | 0.48% | -0.4% | |
| CDLX | Buy | CARDLYTICS INC | $578,000 | +1.2% | 8,740 | +28.5% | 0.47% | +1.9% |
| ELEV | Buy | ELEVATION ONCOLOGY INC | $333,000 | -11.2% | 55,299 | +14.8% | 0.27% | -10.5% |
| SVFA | SVF INVESTMENT CORP | $280,000 | +2.9% | 27,900 | 0.0% | 0.23% | +4.1% | |
| PV | PRIMAVERA CAPITAL ACQUIST CO | $233,000 | -0.4% | 24,000 | 0.0% | 0.19% | 0.0% | |
| SCOAU | SCION TECH GROWTH Iunit 12/17/2025 | $223,000 | 0.0% | 22,410 | 0.0% | 0.18% | +0.6% | |
| PICCU | PIVOTAL INVESTMENT CORP IIIunit 01/28/2028 | $166,000 | 0.0% | 16,800 | 0.0% | 0.14% | +0.7% | |
| HLXA | HELIX ACQUISITION CORP | $158,000 | 0.0% | 16,009 | 0.0% | 0.13% | +0.8% | |
| RMGCU | RMG ACQUISITION CORP IIIunit 02/08/2026 | $109,000 | 0.0% | 11,000 | 0.0% | 0.09% | +1.1% | |
| LUXAW | LUX HEALTH TECH ACQUISITION*w exp 11/30/202 | $57,000 | -26.0% | 66,666 | 0.0% | 0.05% | -24.2% | |
| BTWNW | BRIDGETOWN HOLDINGS LTD*w exp 09/30/202 | $36,000 | -12.2% | 39,773 | 0.0% | 0.03% | -12.1% | |
| KALA | Sell | KALA PHARMACEUTICALS INC | $16,000 | -99.6% | 13,155 | -99.2% | 0.01% | -99.6% |
| FLACW | FRAZIER LIFESCIENCES ACQU CO*w exp 11/30/202 | $12,000 | -14.3% | 21,333 | 0.0% | 0.01% | -9.1% | |
| PVWS | PRIMAVERA CAPITAL ACQUIST CO*w exp 01/19/202 | $8,000 | -20.0% | 12,000 | 0.0% | 0.01% | -12.5% | |
| Exit | CAZOO GROUP LTD*w exp 08/26/202 | $0 | – | -62,500 | -100.0% | -0.08% | – | |
| BOASU | Exit | BOA ACQUISITION CORPunit 99/99/9999 | $0 | – | -34,070 | -100.0% | -0.27% | – |
| SWBKU | Exit | SWITCHBACK II CORPORATIONunit 99/99/9999 | $0 | – | -39,000 | -100.0% | -0.32% | – |
| GIGGU | Exit | GIGCAPITAL4 INCunit 99/99/9999 | $0 | – | -45,000 | -100.0% | -0.37% | – |
| SBBP | Exit | STRONGBRIDGE BIOPHARMA PLC | $0 | – | -8,024,542 | -100.0% | -13.27% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MOLECULAR TEMPLATES INC | 24 | Q2 2023 | 30.7% |
| STRONGBRIDGE BIOPHARMA PLC | 22 | Q3 2021 | 73.1% |
| GARRISON CAP INC | 18 | Q3 2020 | 9.9% |
| BERKSHIRE HATHAWAY INC DEL | 17 | Q3 2019 | 5.8% |
| EIGER BIOPHARMACEUTICALS INC | 17 | Q3 2022 | 1.7% |
| AGILE THERAPEUTICS INC | 16 | Q1 2018 | 55.5% |
| KALA PHARNACEUTICALS INC | 16 | Q4 2021 | 17.6% |
| CM FIN INC | 16 | Q1 2019 | 7.8% |
| SYNTA PHARMACEUTICALS CORP | 15 | Q2 2016 | 99.9% |
| CTI BIOPHARMA CORP | 14 | Q4 2021 | 8.7% |
View CAXTON CORP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Addex Therapeutics Ltd. | February 14, 2023 | 718,849 | 0.9% |
| Cardiff Oncology, Inc. | February 14, 2023 | 983,607 | 2.2% |
| Rezolute, Inc. | February 14, 2023 | 1,860,518 | 5.0% |
| Xeris Biopharma Holdings, Inc. | February 14, 2023 | 5,973,324 | 4.4% |
| CTI BIOPHARMA CORP | February 14, 2022 | 2,239,300 | 2.3% |
| Sierra Oncology, Inc. | February 14, 2022 | 1,119,322 | 7.0% |
| Strongbridge Biopharma plcSold out | January 05, 2022 | 0 | 0.0% |
| SUNESIS PHARMACEUTICALS INCSold out | February 16, 2021 | 0 | 0.0% |
| Alcentra Capital Corp | February 14, 2020 | 1,005,000 | 7.8% |
| Garrison Capital Inc. | February 14, 2020 | 1,223,096 | 7.6% |
View CAXTON CORP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
View CAXTON CORP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.